Babar Ghias
Chief Financial Officer · BIOCRYST PHARMACEUTICALS INC
Individual
- 2025
- Dec 19, 2025
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Babar Ghias files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alane P. Barnes - $3.46M in BCRX purchases and sales in the last 12 months
- Theresa Heggie - $505K in BCRX purchases and sales in the last 12 months
- Amy E. McKee - $100K in BCRX purchases and sales in the last 12 months
- Machelle Sanders - $69K in BCRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Babar Ghias?
Babar Ghias is a corporate insider, tracked as Chief Financial Officer of BIOCRYST PHARMACEUTICALS INC (BCRX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Babar Ghias last file a Form 4?
The most recent primary Form 4 on record is dated 19 December 2025, one of 2 filings going back to 2025.
